MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors. [PDF]
Kotch C +3 more
europepmc +1 more source
Neurofibromatosis type 1: an illustrative case of cutaneous manifestations. [PDF]
Itankar PB, Sawarkar GR.
europepmc +1 more source
Genetic and non-genetic factors influencing phenotypic variability in neurofibromatosis type 1. [PDF]
Clissa PB, Sanabani SS.
europepmc +1 more source
Isolated Anterior Mesenteric Neurofibroma: A Rare Manifestation of Neurofibromatosis Type 1. [PDF]
Ouassil S +11 more
europepmc +1 more source
Neurofibromatosis Type 1 with Plexiform Neurofibroma: A Novel Mutation Uncovered. [PDF]
Garg P +4 more
europepmc +1 more source
Neurofibromatosis type 1-plexiform neurofibromas: Integrating treatment across pediatric and adult populations. [PDF]
Armstrong AE +7 more
europepmc +1 more source
Metachronous Pheochromocytoma and Cholangiocarcinoma in a patient with Neurofibromatosis type 1: a case report. [PDF]
Al Harrak Y +6 more
europepmc +1 more source
Neurofibromatosis type 1 with concomitant Peutz-Jeghers syndrome in a child: a case report. [PDF]
Liu Q, Long Y.
europepmc +1 more source
Emerging Molecular Insights and Therapeutic Directions in Neurofibromatosis Type 1 and NF2-Related Schwannomatosis. [PDF]
Park S +4 more
europepmc +1 more source
A Novel Neurofibromatosis Type 1 (NF1) Frameshift Mutation Associated With Atypical Hypotensive Pheochromocytoma: A Case Report. [PDF]
Kotan R, Göçer EG, Koç MS.
europepmc +1 more source

